Novel small molecules targeting lipid phosphatase SHIP2: new treatments for type 2 diabetes

被引：0
|
作者：
Polianskyte-Prause, Z. [1 ]
Tolvanen, T. A. [1 ]
Lindfors, S. [1 ]
Kon, K. [2 ]
Wang, H. [1 ]
Dumont, V. [1 ]
Groop, P-H. [3 ,4 ,5 ]
Wada, T. [2 ]
Tsuneki, H. [2 ]
Sasaoka, T. [2 ]
Lehtonen, S. [1 ]
机构：
[1] Univ Helsinki, Dept Pathol, Helsinki, Finland
[2] Univ Toyama, Dept Clin Pharmacol, Toyama, Japan
[3] Univ Helsinki, Helsinki, Finland
[4] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland
[5] Helsinki Univ Hosp, Helsinki, Finland
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
496
引用
收藏
页码：S226 / S227
页数：2
相关论文
共 50 条
  • [1] The lipid phosphatase SHIP2 controls insulin sensitivity
    Clément, S
    Krause, U
    Desmedt, F
    Tanti, JF
    Behrends, J
    Pesesse, X
    Sasaki, T
    Penninger, J
    Doherty, M
    Malaisse, W
    Dumont, JE
    Le Marchand-Brustel, Y
    Erneux, C
    Hue, L
    Schurmans, S
    NATURE, 2001, 409 (6816) : 92 - 97
  • [2] The lipid phosphatase SHIP2 controls insulin sensitivity
    Serge Clément
    Ulrike Krause
    Florence Desmedt
    Jean-François Tanti
    Jens Behrends
    Xavier Pesesse
    Takehiko Sasaki
    Joseph Penninger
    Margaret Doherty
    Willy Malaisse
    Jacques E. Dumont
    Yannick Le Marchand-Brustel
    Christophe Erneux
    Louis Hue
    Stéphane Schurmans
    Nature, 2001, 409 : 92 - 97
  • [3] The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man
    Marion, E
    Kaisaki, PJ
    Pouillon, V
    Gueydan, C
    Levy, JC
    Bodson, A
    Krzentowski, G
    Daubresse, JC
    Mockel, J
    Behrends, J
    Servais, G
    Szpirer, C
    Kruys, W
    Gauguier, D
    Schurmans, S
    DIABETES, 2002, 51 (07) : 2012 - 2017
  • [4] Small molecule targeting of SHIP1 and SHIP2
    Kerr, William G.
    Pedicone, Chiara
    Dormann, Shawn
    Pacherille, Angela
    Chisholm, John D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (01) : 291 - 300
  • [5] Regulation of brain insulin signaling by lipid phosphatase SHIP2
    Tsuneki, Hiroshi
    Kagawa, Syota
    Soeda, Yoshiyuki
    Ishihara, Hajime
    Wada, Tsutomu
    Sasaoka, Toshiyasu
    DIABETES, 2006, 55 : A304 - A304
  • [6] Molecular mechanisms of the activation of lipid phosphatase SHIP2 by insulin
    Sasaoka, T
    Ishihara, H
    Wada, T
    Hori, H
    Ishiki, M
    Kobayashi, M
    DIABETES, 2001, 50 : A401 - A401
  • [7] Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes
    Hyvonen, Mervi E.
    Saurus, Pauliina
    Wasik, Anita
    Heikkila, Eija
    Havana, Marika
    Trokovic, Ras
    Saleem, Moin
    Holthofer, Harry
    Lehtonen, Sanna
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 328 (1-2) : 70 - 79
  • [8] Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2
    Suwa, A.
    Yamamoto, T.
    Sawada, A.
    Minoura, K.
    Hosogai, N.
    Tahara, A.
    Kurama, T.
    Shimokawa, T.
    Aramori, I.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (03) : 879 - 887
  • [9] Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity
    Mark W Sleeman
    Katherine E Wortley
    Ka-Man V Lai
    Lori C Gowen
    Jennifer Kintner
    William O Kline
    Karen Garcia
    Trevor N Stitt
    George D Yancopoulos
    Stanley J Wiegand
    David J Glass
    Nature Medicine, 2005, 11 : 199 - 205
  • [10] Correction: Corrigendum: The lipid phosphatase SHIP2 controls insulin sensitivity
    S. Clément
    U. Krause
    F. Desmedt
    J.-F. Tanti
    J. Behrends
    X. Pesesse
    T. Sasaki
    J. Penninger
    M. Doherty
    W. Malaisse
    J. E. Dumont
    Y. Le Marchand-Brustel
    C. Erneux
    L. Hue
    S. Schurmans
    Nature, 2004, 431 : 878 - 878
12345